Recombinant Mouse Serping1 Protein ，His

Serping1, also known as C1 inhibitor (C1-INH), is a crucial serine protease inhibitor that plays a significant role in the regulation of the complement and contact activation cascades. Its primary function is to inhibit the activity of various serine proteases, thereby preventing excessive inflammation and maintaining homeostasis within the immune system. Research into Serping1 has gained momentum due to its involvement in hereditary angioedema (HAE), a genetic disorder characterized by recurrent episodes of severe swelling, often affecting the face, extremities, and gastrointestinal tract. Mutations in the SERPING1 gene lead to either a deficiency or dysfunction of the C1 inhibitor, resulting in uncontrolled activation of the complement and coagulation pathways. Understanding the structure and function of Serping1 is critical for developing targeted therapies for HAE and other conditions associated with dysregulated protease activity. Recent advances in protein engineering and structural biology have enabled researchers to investigate Serping1 in greater detail, revealing its interaction mechanisms with serine proteases and the implications of its dysfunction in various diseases. As research continues, there is potential for innovative therapeutic approaches, including the development of recombinant Serping1 proteins and small molecule inhibitors to restore its regulatory functions or to mitigate the effects of its deficiency in affected individuals. The exploration of Serping1's role in immune regulation not only sheds light on fundamental biological processes but also opens avenues for novel treatments in immunological disorders.